AIkido Pharma Inc
AIKI
Market Cap$19.53M
Close$
$5.90
65.6% upside
Current Fair Value
65.6% upsideUndervalued by 65.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $19.53 Million |
|---|---|
| Enterprise Value | $16.13 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.38 |
| Beta | 0 |
| Outstanding Shares | 10,775,219 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.92 |
|---|---|
| PEG | -0.11 |
| Price to Sales | 1.19 |
| Price to Book Ratio | 1.19 |
| Enterprise Value to Revenue | 0.46 |
| Enterprise Value to EBIT | -0.44 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About AIkido Pharma Inc
CEO: Anthony Hayes AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and res...